The biopharmaceutical company AstraZeneca announced it will $50 billion into the United States, with plans to open several ...

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

With the threat of tariffs looming for medicines imported to the United States, AstraZeneca has unveiled a plan to invest $50 ...

The investment will fund a new drug manufacturing facility in Virginia, and expand research and development in at least 5 ...

Cambridge UK headquartered pharma giant AstraZeneca is investing $50 billion across the US in the next five years, dodging ...

The deal, which Youngkin signed on Monday, has not been reviewed by the Democrat-controlled General Assembly. The governor ...

AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of ...

British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump ...

AstraZeneca says it’ll invest $50 billion in the United States by 2030 as President Donald Trump threatens steep tariffs on drug imports. The pharmaceutical giant Astra Zeneca has announced it's to ...

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States by 2030 amid Donald ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming ...